Company research / MAZE
Maze Therapeutics, Inc. (MAZE)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2024-12-31, Maze Therapeutics, Inc. reported revenue of $167.50M.
Key ratios (year ended 2024-12-31)
34.4%
Operating margin
31.2%
Net margin
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.